# Acceptability of Self-sampling for Cervical Cancer Screening

> **NCT05314907** · NA · UNKNOWN · sponsor: **Institut d'Investigació Biomèdica de Bellvitge** · enrollment: 1614 (estimated)

## Conditions studied

- HPV-Related Cervical Carcinoma
- Self-sampling
- Cervical Cancer Screening

## Interventions

- **DEVICE:** Explanation on how to use self-sampling device and training in the screening visit.
- **OTHER:** Only explanation on how to use self-sampling device.

## Key facts

- **NCT ID:** NCT05314907
- **Lead sponsor:** Institut d'Investigació Biomèdica de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-28
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 1614 (ESTIMATED)
- **Last updated:** 2022-04-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05314907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05314907, "Acceptability of Self-sampling for Cervical Cancer Screening". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05314907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*